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Staphylococcus aureus a-toxin is the archetype of bacterial pore forming toxins and a key virulence
factor secreted by the majority of clinical isolates of S. aureus. Toxin monomers bind to target cells
and oligomerize to form small b-barrel pores in the plasma membrane. Many nucleated cells are
able to repair a limited number of lesions by unknown, calcium-independent mechanisms. Here
we show that cells can internalize a-toxin, that uptake is essential for cellular survival, and that
pore-complexes are not proteolytically degraded, but returned to the extracellular milieu in the
context of exosome-like structures, which we term toxosomes.
 2008 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Staphylococcus aureus a-toxin is the archetype of pore-forming
toxins (PFT) [1–3], and an important virulence factor of S. aureus
[4–14]. It is secreted as a monomer of 34 kDa and binds to a wide
variety of target cells. Membrane-associated a-toxin monomers
assemble into heptameric ring-like structures, which can insert
an amphipathic amino acid sequence to generate a b-barrel tra-
versing the lipid bilayer [15,16]. In erythrocytes, a-toxin induces
colloidosmotic lysis [17], whereas attack on nucleated target cells
causes necrosis [18] or apoptosis [19]. Cell death is, however, not
an inevitable consequence of pore-formation. Previous studies
have documented the capacity of nucleated mammalian cells to
cope with a limited number of membrane lesions and recover from
attack by a-toxin [20–22]. Although mechanical lesions and large
membrane pores, inﬂicted by streptolysin O (SLO), appear to in-chemical Societies. Published by E
-toxin heptamer; CSPL, cell
B, multivesicular bodies; PFT,
blue.
ann).duce rapid calcium-dependent replacement of lesioned membrane
[23,24], a-toxin pores are calcium-impermeable [25], and cannot
be repaired by the wounded membrane response. Notably, repair
of a-toxin pores is slower than repair of the much larger SLO pores,
and the molecular machineries involved are different [26]. Their
precise nature is not known.
While much has been learned about the structure of a-toxin and
themode of pore formation, there is a remarkable gap in our under-
standing of the cell biology of this toxin. In spite of the importance
of S. aureus and of a-toxin, to date virtually nothing is known about
the fate of oligomers after insertion into the plasma membrane of
nucleated cells. Many natural constituents of the plasmamembrane
continuously cycle between the PM and endocytic compartments.
Some are diverted to late endosomes/multivesicular bodies (MVB).
The content of intraluminal vesicles can escape into the cytosol
via the so-called back-fusion or cargo may be transported further
down the degradative pathway by the fusion of MVBs with lyso-
somes. Alternatively, intraluminal vesicles of MVB can be released
to the extracellular milieu as so called exosomes. Their formation
appears to involve at least two distinct pathways [27–29], and they
may confer a multitude of biological effects, including antigen pre-
sentation and dissemination of infectious agents [30,31].lsevier B.V. All rights reserved.
338 M. Husmann et al. / FEBS Letters 583 (2009) 337–344To elucidate the mechanisms of transient membrane perfora-
tion by a-toxin, we set out to study its fate after binding to target
cells, by employing microscopical and biochemical methods. Three
basic ﬁndings were made: ﬁrst, a-toxin can enter nucleated cells,
second, endocytosis rescues cells from attack by small membrane
pores, and third, target cells release undegradable, internalized
toxin in the context of exosomal-like particles.
2. Materials and methods
2.1. Toxin, antibodies, plasmids, chemicals
Wild type S. aureus a-toxin and single amino acid exchange mu-
tant D152C were bacterially expressed and puriﬁed to homogene-Fig. 1. Staphyoloccus aureus a-toxin enters target cells. (A) HaCaT cells were loaded
with wild-type a-toxin on ice as described in the materials and methods section,
and analyzed by confocal immunoﬂuorescence microscopy for a-toxin, and
uvomorulin as a membrane marker. Length bar: 10 lm. (B) Cells were loaded with
toxin as in (A), but subsequently incubated for 2 h at 37 C before analysis.ity as described [16]. Internally radiolabeled a-toxin of high
speciﬁc activity (3000 GBq/mmol) was generated by coupled
in vitro transcription/translation [32]. Labeled non-lytic D152C,
and fully active single amino acid exchange mutant K21C (referred
to as wild type toxin), were thereby obtained. Hemolytic activity
was measured as described [16].
Rabbit anti-a-toxin was from Sigma, and used following prote-
inA-afﬁnity puriﬁcation; mAb anti-uvomorulin was from SANTA
CRUZ BIOTECHNOLOGY INC., Alexa-Fluor-conjugates were from
MOLECULAR PROBES, molecular weight marker from CELL SIGNAL-
LING, and 4,6-diamidino-2-phenylindole dilactate (DAPI) from
MERCK BIOSCIENCES. L-35S-Methionine was purchased from GE
HEALTHCARE.
2.2. Cells and culture conditions
HaCaT cells, human non-virally transformed keratinocytes [33]
were obtained from Cell Lines Services (CLS), Eppelheim, Germany.
Human hepatoma cells, (Huh7), were kindly provided by Dr. C.
Lambert (Institute of Medical Microbiology and Hygiene, Univer-
sity of Mainz, Germany). Cos7 and HEK 293 cells were obtained
from DSMZ, Braunschweig, Germany. All cells were cultured in
DMEM supplemented with 10% FCS. For subculturing, they were
detached by trypsinization, counted and seeded into tissue culture
plates of various formats (NUNC). Subculturing was done 24 h
prior to application of the various treatment protocols, so that at
the time of treatment cell density had reached approximately 80%.
Unless stated otherwise, treatment of cells with unlabeled or la-
beled a-toxin (500 ng/ml) was generally performed as outlined in
Fig. 2A. The loading protocol was used to synchronize uptake,
but internalization of toxin was also observed when cells were
continuously exposed to a-toxin under normal culture conditions.
2.3. Immunoﬂuorescence microscopy
Cells were seeded onto glass cover slips in 6-well culture plates,
1 day prior to treatment protocols or transfections. Following
treatment protocols, cells were washed in PBS, ﬁxed with 2% para-
formaldehyde for 5–10 min at RT, permeabilized with 0.1% Triton
X-100 or prechilled methanol at 20 C for 5 min if not stated
otherwise, and sequentially reacted with primary antibodies, and
ﬂuorescently labeled secondary antibodies. Stained cells were
embedded in Moviol. Confocal images were obtained using a
ZEISS 510 Meta microscope equipped with a Plan-Apochromat
63/1.4 oil objective. Wide ﬁeld immuno-ﬂuorescence microscopy
was performed with a ZEISS Axiovert 200M microscope, using a
Plan-Apochromat 100/1.4 oil objective; digital images were ac-
quired with a ZEISS AxioCam and processed with Axiovision soft-
ware and Adobe Photoshop.
2.4. ATP-assay
Intracellular ATP-levels were measured as described previously
[19] with minor modiﬁcations. In brief, HaCaT cells were seeded at
a density of 2  104 per well into 96-well tissue culture plates. Tox-
in treatment was performed 24 h later, and intracellular ATP levels
were measured with the ATP Bioluminescence Assay kit CLS II from
ROCHE using a Lumat 9705 instrument from BERTHOLD (BadWild-
bad, Germany).
2.5. Quantitation of surface-exposed and total cell-associated a-toxin
Cell surface protein labeling (CSPL) was used to detect internally
S35-methionine-labeled a-toxin exclusively on the cell surface,
while immunoprecipitation (IP) was employed to detect a-toxin
associated with both cell surface and interior. For the IP protocol,
Fig. 2. Both a-toxin 1mers and 7mers are internalized by cells. (A) Work ﬂow of the cell surface protein labeling (CSPL) protocol for the detection of a-toxin on cell surface, and
the immunoprecipitation (IP) protocol for detection of total cell associated toxin. Blue labeling indicates CSPL-speciﬁc steps. SA denotes streptavidin-coupled beads, PAGE
denotes polyacrylamide gel electrophoresis, LSC denotes liquid scintillation counting of excised bands. (B) Kinetics of a-toxin surface-exposure. CSPL was performed with
toxin-loaded HaCaT cells after incubating cells for various times at 37 C. (C) Cells were loaded with radio-labeled a-toxin as in B, but total toxin was retrieved by
immunoprecipitation after the indicated times. (D) Time course of total vs. surface-exposed SDS-stable 1mers; data are mean values of three independent
experiments ± S.E.M. (E) Time course of total vs. surface-exposed SDS-stable 7mers; data are mean values of three independent experiments ± S.E.M.
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500 ng internally labeled S35methionine-a-toxin, in 2.0 ml DMEM
for 40 min on ice. Unbound activity was removed by washing cells
twice with 5 ml ice cold PBS, before 5 ml DMEM was added and
incubation at 37 C was started. Cells were harvested with a cell-
scraper, spun down in an Eppendorf-tube, washed twice with PBS
and lyzed in 1 ml of 50 mM Tris–HCL, 300 mM NaCl, containing
200 ng/ml leupeptin, 2 mg/ml Aprotinin and 2% v/v of NP40. For
immunoprecipitation, preclearing of lysates was performed with
30ll of Protein A-Agarose (ROCHE) at 4 C for 2 h. Subsequently,
2 ll of anti–toxin (Sigma) were added and the mixture was incu-
bated on ice for 1 h. Immune-complexes were harvested by addi-
tion of 30 ll of protein A-agarose and incubation on ice o/n,
collection of agarose by centrifugation, washing, and incubation
of agarose-beads in Laemmli-buffer without b-mercaptoethanol
for 10 min at 50 C. Proteins were separated by SDS–PAGE (10%),
and labeled a-toxin was revealed by ﬂuorography.
To measure changes of the amounts of a-toxin on the cell sur-
face over time or in response to certain treatments, cells were
loaded with internally labeled toxin and incubated for varioustimes at 37 C and subsequently cell surface proteins were labeled
with a non-membrane-permeant biotinylation reagent (EZ-Link
Sulfo-NHS-SS-Biotin; Cell Surface Protein Isolation kit, PIERCE),
and precipitation of labeled material was achieved with streptavi-
din-coupled beads as suggested by the supplier. Isolated a-toxin
monomer (1mers) and stable a-toxin heptamer (7mers) were sepa-
rated by electrophoresis, detected by ﬂuorography and/or quanti-
ﬁed by liquid scintillation counting.
2.6. Preparation and analysis of exocytic particles
Exosomes were essentially prepared as described previously
[34]. In brief, HaCaT cells were seeded into T75 ﬂasks (5  106 cells
each), loaded with internally radiolabeled a-toxin (500 ng/ml,
40 min on ice), washed twice in cold PBS, and 10 ml complete
DMEM was ﬁnally added per ﬂask. Cells were then incubated for
2 h at 37 C, washed again in PBS and 10 ml DMEM was added.
After incubating cells for 24 h at 37 C, supernatants were collected
and sequentially centrifuged at 300  g, 1200  g and 10000  g,
70000  g and 100000  g as described. Pellets were dissolved in
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were analyzed by ﬂuorography to reveal a-toxin; mass spectro-
metric protein analysis of the 70000  g pellet was performed as
described in the legend of Supplementary Table 1, and immuno-
electron microscopy essentially as described by Raposo et al. InFig. 3. Cell type-dependent internalization of a-toxin – correlation with survival. (A) Surf
onto Huh7 cells and incubation at 37 C for the indicated times. Recovery of toxin from
toxin-recovery from these cells, but causing partial dissociation of 7mers into 1mers. Alth
as in HaCaT cells (not shown). (B) Huh7 cells were loaded with non-lytic a-toxin muta
transferrin. Subsequently, cells were analyzed by confocal microscopy. Arrows point to im
with a-toxin in the cold and then incubated for the indicated times at 37 C before ce
untreated controls run in parallel for each time point. Mean values ± S.E.M from three ibrief, pellets were generated as described above, resuspended in
100 ll media, placed on grids, sequentially reacted with rabbit-
anti-a-toxin and 10 nm gold-conjugated anti-rabbit serum (TEBU).
Uranyl-acetate (2%) was used for contrasting. Images were taken
with a ZEISS EM 902 instrument.ace-exposed a-toxin was recovered by CSPL at various time points following loading
SA-beads was performed at 80 C (instead of 50 C) in this experiment, improving
ough recovery of toxin at 50 C yielded weaker bands, 7mer/1mer-ratios were similar
nt D152C in the cold and incubated for 2 h at 37 C in the presence of Alexa-594-
muno-stained a-toxin D152C decorating the surface of cells. (C) Cells were loaded
llular ATP and Trypan-blue exclusion (Tbl) were assessed. The data represent % of
ndependent experiments are shown.
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Data shown are representative of three or more independent
experiments, unless otherwise stated. P-values were calculated
using two-tailed, unpaired Student´s t-test.
3. Results and discussion
3.1. S. aureus a-toxin can enter nucleated cells
After loading cells with a-toxin at 4 C, binding to the plasma
membrane was readily detected by confocal immunoﬂuorescence
microscopy (Fig. 1A). When toxin-loaded cells were incubated at
37 C for 2 h, a-toxin assumed a punctuate pattern of predomi-
nantly intracellular localization (Fig. 1B), demonstrating for the
ﬁrst time that a-toxin can enter target cells.
A novel procedure was then devised to quantify changes of sur-
face-exposed or total cell-associated toxin, thereby distinguishing
between stable heptamers (i.e. pore complexes) or monomers/
prepores (Fig. 2A). Gels showing surface-associated or total cell
associated a-toxin are depicted in Fig. 2B and C, respectively, and
the time course of monomer- and SDS-stable oligomer-recovery
from cell surface and from total cell-lysates is summarized in
Fig. 2 D and E. From these data it was concluded that a substantial
fraction of monomers/prepores and most of the SDS-stable pore
complexes enter cells.
3.2. Internalization of a-toxin is required for cellular recovery
Next we investigated the fate of a-toxin in other cell lines.
While Cos7 cells also removed toxin from their surface (not
shown), the contrary was observed in Huh7 cells: Even after 5 h
at 37 C, a-toxin remained accessible to surface biotinylation
(Fig. 3A). The failure of Huh7 cells to remove a-toxin from the sur-
face was not secondary to ATP-loss, because the non-toxic single
amino acid exchange mutant D152C also persisted on the plasma
membrane of these cells. Persistence of toxin on the membrane
of Huh7 cells was conﬁrmed by immunoﬂuorescence analysis
(Fig. 3B), and similar results were obtained with HEK293 cells
(not shown).
The ﬁnding that a-toxin-persistence in the plasma membrane
was cell type-dependent, led us to investigate whether uptake of
toxin correlated with the ability to survive attack by the pore for-
mer. Viability was assessed by ATP-measurements and Trypan-
blue exclusion. As shown in Fig. 3, panel C, a, Huh7 cells did not
recuperate from the loss of ATP following loading with a-toxin,
and became permeable for Trypan-blue. Similar results were ob-
tained with HEK293 cells (Fig. 3, panel C, b). In contrast, HaCaT
and Cos7 cells, which were found to be efﬁcient at internalizing
a-toxin, replenished their ATP-pools within hours, and remained
impermeable for Trypan-blue (Fig. 3, panel C, c and d). Thus, the
ability of a cell-type to survive membrane perforation by a-toxin
appeared to depend on its ability to internalize the toxin. To con-
ﬁrm or refute a role of endocytosis for defense against a-toxin,
we sought a second experimental approach.
Various mechanisms of endocytosis, including clathrin-depen-
dent [35] and clathrin-independent pathways [36], depend on dyn-
amin. This large GTPase can be speciﬁcally inhibited with the
recently described small molecular weight inhibitor dynasore
[37]. Immunoﬂuorescence microscopy, as well as the combined
use of CSPL and IP, revealed that internalization of a-toxin in Ha-
CaT cells was efﬁciently blocked by dynasore (Fig. 4A–C). This al-
lowed us to assess the effect of membrane-persistence of a-toxin
on cells that were naturally internalization-competent. As depicted
in Fig. 4D and E, dynasore impaired recovery of ATP-levels after
permeabilization by a-toxin, and enhanced cell death.3.3. Endocytosed a-toxin reaches late endosomes and disappears
slowly from cells; loss of oligomers is not sensitive to baﬁlomycin
Next we performed double staining experiments with antibod-
ies against CD63/Lamp3, which revealed colocalization of internal-
ized a-toxin with this marker of late endosomes andmultivesicular
bodies (Fig. 5A) [38].
When immunoﬂuorescence-analysis of cells was performed at
4 h, 8 h and 22 h following loading with a-toxin staining of inter-
nalized toxin became increasingly fainter (Fig. 5B). Similar results
were obtained when ﬂuorescently-labeled toxin was used for
microscopy instead of indirect immunoﬂuorescence technique
(not shown).
To test whether the apparent loss of toxin depended on endo-
somal acidiﬁcation, toxin-loaded cells were cultured in the presence
or absence of baﬁlomycin, and a-toxin was then recovered by IP after
various times of incubation. Degradation of 1mers could be discerned
in samples without baﬁlomycin, but not in samples that had received
the drug (Fig. 5C), proving the efﬁcacy of the treatment. Monomers in
control samples disappeared more rapidly than in baﬁlomycin-trea-
ted cells, and this loss was accompanied by appearance of a faster
migrating protein species. In contrast, obvious break down products
of 7mers were not observed in either controls or baﬁlomycin-treated
cells, and baﬁlomycin-treatment did not increase the yield of 7mers
after prolonged incubation. Therefore, loss of a-toxin from cells could
not be accounted for by degradation.
3.4. Undegraded a-toxin is expelled from cells in the context of
exosomal structures – toxosomes
In order to gain further insights into the fate of internalized tox-
in we quantiﬁed the radioactivity derived from internally labeled
a-toxin in acetone precipitates of supernatants and in cell lysates.
Acetone soluble counts reached 5% (2 h) and 10% (24 h) of the
total activity, suggesting that degradation of monomers was
incomplete yielding mostly acetone precipitable polypeptides dur-
ing that period. As depicted in Fig. 5D, increasing amounts of ace-
tone-precipitable activity became retrievable in the supernatant
with a concomitant loss in cell lysates, suggesting that cells might
release internalized toxin. Sequential centrifugations at 300  g,
1200  g, 10000  g, 70000  g and 100000  g were performed
with supernatants that were obtained 1 day after toxin-internali-
zation. When pellets were analyzed by SDS–PAGE and ﬂuorogra-
phy, a-toxin was found in the 300  g pellet, corresponding to
dead cells and debris, but also in the 70000  g pellet. Whereas
most of the toxin in dead cells was oligomerized, the 70000  g
pellet contained both oligomers, some of which migrated as bands
of higher apparent MW, and monomers (Fig. 5E). Since oligomers
are SDS-stable, and dead cells contained toxin almost exclusively
in the oligomeric form, monomers in the 70000  g fraction are
not from dead cells. Therefore, toxin in the 70000  g fraction orig-
inated from live cells.
Reportedly, the 70000  g pellet is enriched for exosomes [34],
and a protein proﬁle obtained by mass spectrometry of our prepa-
ration closely resembled proﬁles from previous studies of exosome
preparations [39–41], (Supplementary Table 1). Therefore,
70000  g pellets were subjected to ﬂotation on a sucrose gradient,
and fractions were analyzed byWestern-blot for the presence of a-
toxin and known exosomal marker proteins. As shown in Fig. 5F, a-
toxin 1mers, 7mers and ﬂotillin co-fractionated in the sucrose gra-
dient; similar results were obtained when blots were developed
with antibodies against alix or CD63 (data not shown). Impor-
tantly, the density of fractions containing the highest amounts of
toxin and ﬂotillin was 1.12 g/ml, a value that has been reported
for exosomes. In line with these data, immunogold electron
microscopy of the 70000  g pellet revealed abundant spherical
Fig. 4. (A) Cells cultured on cover slips were pretreated with dynasore (80 lM), or solvent alone for 1 h, loaded with a-toxin on ice and subsequently ﬁxed immediately or
after incubation for 2 h at 37 C, with inhibitor or solvent alone permanently present. a-Toxin was detected by immunoﬂuorescence microscopy using a wide ﬁeld
microscope. (B) HaCaT cells were pretreated with solvent, or dynasore at the indicated concentrations, loaded with internally labeled toxin, washed and surface biotinylated
immediately, or after culturing cells for 2 h at 37 C. Lysates were obtained, sequentially subjected to SA-pull-down and IP, and the recovered material was analyzed by SDS–
PAGE and ﬂuorography. Surface-exposed 7mers are shown in the upper panel, while 7mers recovered by subsequent IP from the same lysates (internalized 7mers, denoted
‘‘internalized”) are shown in the lower panel. (C) Quantitation of surface-exposed 7mers in dynasore-treated vs. control cells. Data were obtained as described for the upper
panel of (B), and represent mean values of three independent experiments with error bars indicating ±S.E.M. ** denotes p < 0.02. (D) HaCaT cells were preincubated with
dyansore (80 lM) or solvent alone for 1 h, loaded with a-toxin (500 ng/ml) in the cold, and then incubated at 37 C for the indicated times before ATP was measured;
dynasore/solvent were present throughout. Data represent % of untreated controls; mean values of three independent experiments ±S.E.M. are given. (E) HaCaT cells were
pretreated as in (D), and cultured for 40 h. Propidium iodide positive cells were enumerated by ﬂow cytometry on a FACScan machine (B and D); data are displayed as fold
activation over untreated controls with data-points representing mean values of three independent experiments, error bars: ±S.E.M.
342 M. Husmann et al. / FEBS Letters 583 (2009) 337–344structures which heavily stained with anti-a-toxin (Fig. 5G); we
term these structures toxosomes.
Bona ﬁde a-toxin monomers are susceptible to proteolytic deg-
radation [42]. That internalized monomers are partially regurgi-
tated in an undegraded form might indicate that a fraction of a-
toxin does not reach a degradative environment. An alternative
explanation may be that these monomers could be mainly derived
from pre-pores (i.e. heptamers not yet fully inserted into the bi-
layer), which might be similarly resistant to proteolytic destruction
as SDS-stable heptamers. In any case, cells appear to circumvent
the problem by disposing of a-toxin by externalization.Future work will address mechanisms and consequences of
a-toxin exocytosis, which might be the only way for a cell to
eliminate SDS-stable a-toxin oligomers. It is not excluded that
intracellular accumulation of oligomers eventually perturbs cellu-
lar functions, possibly akin to proteins involved in neurodegenera-
tive diseases. Whether other toxins, including PFT that unfold their
activity primarily inside cells, like aerolysin [43], are also exocyto-
sed, needs to be clariﬁed. Finally, a role of toxosomes in antigen-
presentation or signalling warrants further investigations.
In summary, it is shown here for the ﬁrst time that some nucle-
ated cell types are able to endocytose S. aureus atoxin. Second,
Fig. 5. Target cells release toxosomes (A) Cells were loaded with a-toxin (500 ng/ml) on ice, incubated at 37 C for 2 h, double-stained for CD63/LAMP3 and a-toxin, and
analyzed by confocal microscopy. Arrows indicate colocalization of a-toxin and CD63/Lamp3. (B) Immunoﬂuorescence microscopy was performed with HaCaT cells
immediately following loading with a-toxin (500 ng/ml) on ice see Section 2, or at the indicated time points following subsequent incubation at 37 C. (C) Cells were treated
with baﬁlomycin (200 nM) or solvent for 1 h prior to loading with internally labeled toxin (500 ng/ml). Cells were cultured for the indicated times in the continuous presence
of the inhibitor, and cell-associated toxin was analyzed by IP. The arrow indicates a degradation product in control samples. (D) After loading, cells (106) were allowed to
internalize the bulk of toxin, washed and incubated at 37 C for various times. Acetone-precipitable activity was measured in cell-free supernatants (sup), adherent cells
(cells) and detached cells. Acetone soluble activity reached 5% and 10% of the total activity at 4 h and 24 h, respectively. Data represent % of internalized activity; the mean
of three independent experiments is shown, error bars indicate ±S.E.M. (E) a-Toxin-monomers and -oligomers are released into the extracellular milieu. Supernatants were
collected after loading of cells with labeled toxin in the cold, incubation for 3 h at 37 C, washing and incubation for another 22 h. Pellets obtained by the indicated steps of a
sequential centrifugation protocol were analyzed by SDS–PAGE and ﬂuorography. (F) A 70000  g pellet as shown in (E) was further separated on a continuous sucrose
density gradient. Fractions were collected and analyzed by Western-blot for the presence of a-toxin, and ﬂotillin as an exosomal marker protein. Membrane fractions with a
density of 1.12 g/ml contained the highest amount of both ﬂotillin and a-toxin. (G) Immunoelectron microscopy of 70000  g pellet revealed numerous a-toxin-
immunoreactive spherical structures, which were completely absent from pellets of 10000  g and 100000  g spins. A representative proﬁle is shown. Gold particles are
10 nm.
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344 M. Husmann et al. / FEBS Letters 583 (2009) 337–344internalization of toxin is required for cellular survival. The data
provide a conclusive explanation for the long-standing enigma of
transient membrane perforation by a-toxin [20,21], and suggest
a role of endocytosis as an innate cellular defence mechanism
against small membrane pores. Third, release of toxosomes enables
cells to eliminate a virtually undegradable complex comprising a
bacterial virulence factor.
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